Targeted biological treatment of non‑small cell lung cancer
Prof. MUDr. Jana Skřičková, CSc.; MUDr. David Petr
Klinika nemocí plicních a tuberkulózy LF MU a FN Brno
In recent years, non-small cell lung carcinoma (NSCLC) treatment has developed rapidly. Biological treatment preparations have improved survival in NSCLC, particularly in non-operable locally advanced and metastatic NSCLC. Substances that target the processes inside tumor cells are particularly useful in adenocarcinomas. At the time of diagnosis, it is necessary to determine the morphological diagnosis as accurately as possible and, if indicated, to perform genetic testing. In our paper we give an overview of the development and possibilities of biological treatment.
non-small cell lung cancer, advanced disease, biological treatment
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...